August 15, 2020
Maintenance Avelumab Improves Survival in Advanced Bladder CancerBookmarkGeorge Lundberg, MD
Article from The ASCO Post curated by Editor in Chief George Lundberg, MD, who notes:
In a clinical trial for certain patients with advanced urothelial carcinoma, overall survival was prolonged by about 30% by using supportive care plus maintenance treatment with the drug avelumab, versus supportive care alone.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.